Growth or antigrowth: Angiotensin and the endothelium

Journal of Hypertension

Volumn 13, Issue 12, 1995, Pages 1529-1534

  Stoll, Monika ^a   Meffert, Simone ^a   Stroth, Ursula ^a   Unger, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Angiotensin II; Angiotensin receptors; Endothelial cells; Growth factors; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CONFERENCE PAPER; HEART MUSCLE CAPILLARY; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

EID: 0029584672     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Messerli FH, Ketelhut R: Left ventricular hypertrophy: an independent risk factor, J Cardiovasc Pharmacol 1991, 17 (suppl 4): 59-67.
2. Rakugi H, Kim DK, Krieger RE, Wang DS, Dzau VJ, Pratt RE: Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994, 93:339-364.
3. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991, 68:450-456.
4. Flakenhahn M, Franke F, Bohle RM, Zhu YC, Stauss HM, Bach- mann S, et al.: Cellular distribution of angiotensin converting enzyme after myocardial infarction. Hypertension 1995, 25:219-226.
5. Brilla CC, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991, 83:1771-1779.
6. Childs TJ, Adams MA, Mak AS: Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins. Hypertension 1990, 16:662-668.
7. Linz W, Schölkens BA, Canten D: Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 1989, A11:1325-1350.
8. Dunn FC, Oigman W, Ventura OH, et al.: Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol 1984, 53:105-108.
9. Nakashima Y, Fouad FM, Tarazi RC: Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 1984, 53:1044-1049.
10. Clozel JP, Kuhn H, Hefti F: Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension, J Hypertens 1989, 7:267-275.
11. Odori T, Paskins-Hurlburt A, Hollemberg NK: Increase in collateral arterial endothelial cell proliferation induced by capto- pril after renal artery stenosis in the rat. Hypertension 1983, 5:307-312.
12. Unger T, Mattfed T, Lamberty V, Bock P, Mall C, Linz W, et al.: Effects of early-onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 1992, 20:476-482.
13. Aceto JF, Baker KM: (Sari)angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 1990, 258.H806-H813.
14. Berk BC, Vekhstein V, Cordon HM, Tsuda T: Angiotensin II- stimulated protein synthesis in cultured vascular smooth muscle ceils. Hypertension 1989, 13:305-313.
15. Geisterfer AAT, Peach MJ, Owens CK: Angiotensin II induces hypertrophy but not hyperplasia of cultured rat aortic smooth muscle cells. Circ Res 1990, 62:749-756.
16. Gottwik M, Puschmann S, Wuesten B, Nienaber C, Muller KD, Hofmann M, et al.: Myocardial protection by collateral vessels during experimental coronary ligation: a prospective study in a canine two-infarct model. Basic Res Cardiol 1984, 79:337-343.
17. Tomanek RJ, Wessel TJ, Harrison DG: Capillary growth and geometry during long-term hypertension myocardial hypertrophy in dogs. Am J Physiol 1991, 261: H1011-H1018.
18. Crisman RP, Rittmann B, Tomanek RJ: Exercise-induced myocardial growth in the spontaneously hypertensive rat. Microvasc Res 1985, 30:185-194.
19. Hudlicka O: Growth of capillaries in skeletal and cardiac muscle. Circ Res 1990, 50:451-461.
20. Schaper W, deBrabander M, Levi P: DNA synthesis and mitosis in coronary collateral vessels of the dog. Circ Res 1971, 28:671-679.
21. Quinkler W, Maasberg M, Bernotat-Danielowski S, Lüthe N, Sharma HS, Schaper W: Isolation of heparin-binding growth factors from bovine, porcine and canine hearts. Eur J Biochem 1989, 181:67-73.
22. Casscells W, Speir E, Sasse J, Klagsburn M, Allen P, Lee M, et al.: Isolation, characterization, and localization of heparinbinding growth factors in the heart, J Clin Invest 1990, 85:433-441.
23. Meininger C, Granger H: Mechanism leading to adenosine- stimulated proliferation of microvascuiar endothelial cells. Am J Physiol 1990, 258: H198-H206.
24. Fernandez LA, Twickler J, Mead A: Neovascularization produced by angiotensin II. J Lab Clin Med 1985, 105:141-145.
25. LeNoble FAC, Schreurs NHJS, Van Straaten HWM, Slaaf DW, Smits JFM, Rogg H, et al.: Evidence for a novel angiotensin II receptor involved in angiogenesis in chick chorioallantoic membrane. Am J Physiol 1993, 264: R460-R465.
26. Metsärinne KP, Stoll M, Gohlke P, Paul M, Unger T: Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharm Pharmacol Lett 1992, 2:150-152.
27. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, et al.: Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989, 165:196-203.
28. Criscione L, Thomann H, Whitebread S, deGasparo M, Buhlmayer P, Herold P, et al.: Binding characteristics and vascular effects of various angiotensin II antagonists. J Cardiovasc Pharmacol 1990, 16 (suppl 4): S56-S59.
29. deGasparo M, Whitebread S, Mele M, Montani PJ, Ramjoue HP, Kamber B: Biochemical characterization of two angiotensin II receptor subtypes in the rat. J Cardiovasc Pharmacol 1990, 16 (suppl 4): S31-S35.
30. Baukal AJ, Balia T, Hunyady L, Hausdorff W, Guillemette G, Catt KJ, et al.: Angiotensin II and guanine nucleotides stimulate formation of inositol 1, 4, 5-trisphosphate and its metabolites inpermeabilized adrenal glomerulosa cells. J Biol Chem 1988, 263:6087-6092.
31. Garrison JC, Johnson DE, Campanile CP: Evidence for the role of phosphorylase kinase, protein kinase C and Ca2+-sensitive protein kinases in the response of hepatocytes to angiotensin II and vasopressin. J Biol Chem 1988, 259:3283-3292.
32. Naftilan AJ, Pratt RE, Eldridge CS, Dzau VJ: Angiotensin II induces c-fos expression in smooth muscle cells via transcriptional control. Hypertension 1989, 13:706-711.
33. Kawahara Y, Sunako M, Tsuda T, et al.: Angiotensin II induced expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1988, 150:52-59.
34. Dzau VJ, Gibbons GH, Pratt RE: Molecular mechanisms of vascular renin-angiotensin-system in myointimal hyperplasia. Hypertension 1991, 18 (suppl 2): 100-105.
35. Stouffer GA, Owens GK: Angiotensin ll-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor 3,. Circ Res 1992, 70:820-828.
36. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, De- leafontaine P, et al.: Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995, 375:247-250.
37. Darnell JE, Kerr IA, Start GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
38. Mukoyama M, Nakajama M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ: Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors, J Biol Chem 1993, 268:24539-24542.
39. Kambayashi Y, Bardhan S, Tahahashi K, Tzuzuki S, Inui H, Hamakubo T, et al.: Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition, J Biol Chem 1993, 268:24543-24546.
40. Buisson B, Bottari SP, deGasparo M, Gallo PN, Payet MD: The angiotensin II AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells. FEBS Lett 1992, 309:161-164.
41. Bottari SP, Taylor V, King IN, Bogdal S, deGasparo M: Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteins, Eur J Pharmacol 1991, 207:157-163.
42. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T: The angiotensin AT2 receptor mediates inhibition of cell proliferation in coronary endothelial cells, J Clin Invest 1995, 95:651-657.
43. Nakajima M, Horiuchi M, Morishita R, Yamada T, Pratt RE, Dzau VJ: Growth inhibitory function of type 2 angiotensin receptor: gain of function study by in vivo gene transfer [abstract 37]. Hypertension 1994, 24:379.
44. Trouch D, Grigoriev G, Lenormand JL, Robin P, Leibovitch SA, Sassone-Corsi P, et al.: Repression of c-fos promotor by MyoD on muscle cell differentiation. Nature 1993, 363:79-82.
45. Steckelings UM, Stoll M, Wagner J, Unger T: Differential regulation of immediate early gene expression via angiotensin receptor subtypes AT1 and AT2 [abstract 829]. J Hypertens 1994, (suppl 3): S150.
46. Unger T, Stoll M, Jonas U, Hahn AWA: Isolation of differentially expressed genes in PC12w cells after stimulation of AT2 receptors [abstract 472]. Naunyn Schmiedebergs Arch Pharmacol 1995, 351 (suppl): R118.
47. Pratt RE, Wang D, Hein t, Dzau VJ: The AT2 isoform of the angiotensin II receptor mediates myointimal hyperplasia following vascular injury [abstract P52], Hypertension 1992, 20:433.
48. Lopez JJ, Lorell BH, Inglefinger JR, Weinberg EO, Schunkert H, Diamant D, et al.: Distribution and function of cardiac angiotensin AT1 and AT2 receptor subtypes in hypertrophied rat hearts. Am J Physiol 1994, 267: H844-H852.